Reaction profile

The FDA adverse-event record for application site haemorrhage

32 FDA reports name application site haemorrhage, a lower-volume reaction in the CVM extract (VeDDRA 11). Plate stamps and neighbourhood peers follow.

#1952 of 2,481
by report volume (all reactions)
32
reports citing this reaction
3.1%
death-coded share
Cat
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Application site haemorrhage has 32 reports now versus 32 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Application site haemorrhage changes

FDA AER · VeDDRA plate

Code 11 VOL-TRACE

VOL-TRACE · DEATH-LOW · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 32 reports
  • DEATH-LOW 3.1%
  • LOWER-Q #1952/2481
  • PHOTO-FINISH ANION GAP HI, BLD
  • SPECIES-CAT Cat · 17
  • DRUG-LEAD Selamectin · 10
  • DESK-WIDE 19 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: ANION GAP HI, BLD (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Application site haemorrhage

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348ANION GAP HI, BLD · near32Application site haem… · thi…32Convulsive disorder N… · near32Copper toxicity signs · near32Dysmetria · near32Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Application site haemorrhage

Application site haemorrhage: low death-coded share in the FDA AER plate

Signature read: 1 death-coded reports is a thin tail count for Application site haemorrhage in the CVM extract. Report volume is lower-third scale: 32 named reports in the openFDA extract. Death-coded share is lower-third: 1 of 32 reports (3.1% of named reports). Nearest volume peer: ANION GAP HI, BLD (±0 reports). Lead species Cat (17). Lead co-reported drug Selamectin (10).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Selamectin appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 17
Dog 14
Unknown 1

Breeds Most Affected

Domestic Shorthair 13
Domestic Longhair 2
American Shorthair 1
Collie - Border 1
Mixed (Dog) 1
Collie - Smooth-haired 1
Shepherd Dog - German 1
Crossbred Canine/dog 1
Spaniel - Cocker American 1
Terrier - Yorkshire 1

Associated Drugs

Selamectin 10
Imidacloprid + Moxidectin 5
Carprofen 4
Florfenicol/Terbinafine Hydrochloride/Mometasone Furoate 3
Tromethamine/Disodium Edta/Ketoconazole 3
Saline 3
Ciprofloxacin 2
Otic Flush 2
Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride 2
Fluralaner/Moxidectin Spot-On 2
Antihistamines 1
Unspecified Anesthetic 1
Prednisone 1
Famotidine 1
Tramadol 1
Device: Ligating Clips For Surgery 1
Flumethrin-Imidacloprid 1
Device: Surgical Instruments 1
Mirtazapine 1
Odansetron 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Application site haemorrhage (#1952 of 2,481 by report volume); death-coded 3.1%. PlainBreed reaction plate · death-coded report count stamp 1 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →